From the NIH: Implications of the recent beta-blocker clinical trials for patients after myocardial infarction.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control; D012008:Recurrence
D000319:Adrenergic beta-Antagonists